Vitamin K2: The Fat-Soluble Vitamin in Grass-Fed Organ Meats
Most people have heard of Vitamin K, the nutrient associated with blood clotting. What fewer people know is that Vitamin K exists in two fundamentally different forms, and that confusing them has led to decades of missed opportunity in nutritional science. Vitamin K1 (phylloquinone) handles coagulation. Vitamin K2 (menaquinone) does something else entirely: it directs calcium to the right places in your body, into bones and teeth, and away from arteries and soft tissue. These are not minor variations on the same theme. They are distinct nutrients with distinct functions, and only one of them is found in meaningful concentrations in grass-fed animal organs.
Understanding why this distinction matters (and why the source of your K2 determines how much you actually absorb) requires looking at both the biochemistry and the agriculture. This post covers both.
MK-4 vs. MK-7: Two Forms of Vitamin K2 That Are Not Interchangeable
Vitamin K2 is a family of molecules called menaquinones, differentiated by the length of their side chain. The two forms most relevant to human health are MK-4 (menaquinone-4) and MK-7 (menaquinone-7). MK-4 is the form found predominantly in animal tissues: liver, brain, kidney, egg yolks, and butter from pasture-raised animals. MK-7 is produced by bacteria and is found in fermented foods, most notably the Japanese fermented soybean product natto. These two forms differ in half-life, tissue distribution, and biological activity in ways that matter clinically.
MK-4 has a short half-life of roughly one to two hours in circulation but is the form that accumulates in bone, brain, and arterial tissue, precisely the organs where K2 performs its most critical regulatory work. MK-7, with its longer half-life of approximately three days, remains in circulation longer and has been the subject of several well-designed clinical trials on bone density. Research published in Osteoporosis International (Knapen et al., 2013) demonstrated that MK-7 supplementation at 180 mcg daily over three years improved bone mineral density and bone strength in postmenopausal women. Both forms activate carboxylation-dependent proteins (the key mechanism by which K2 exerts its biological effects), but they do not simply substitute for one another in every tissue context. The most physiologically complete picture comes from obtaining both forms through a varied ancestral diet.
The Calcium Paradox: Why Vitamin K2 Is Central to Cardiovascular Health
One of the most important paradigm shifts in nutritional cardiology over the past two decades has been the recognition that calcium consumption and cardiovascular risk are mediated not just by total intake but by where calcium ends up depositing. Arterial calcification, the hardening of arterial walls through calcium deposits, is a well-established independent risk factor for cardiovascular events. For decades, the assumption was that this process was largely passive, an inevitable consequence of aging or excess calcium intake. Research on Vitamin K2 has challenged that assumption.
The Rotterdam Study, a large prospective cohort study published in the Journal of Nutrition (Geleijnse et al., 2004), followed over 4,800 adults for seven years and found that higher dietary intake of K2 (specifically from animal sources and fermented foods) was associated with reduced coronary calcification and lower all-cause mortality. Crucially, K1 intake showed no such association. The mechanism centres on Matrix Gla Protein (MGP), a vitamin K-dependent protein that is the most potent known inhibitor of arterial calcification. Without adequate K2, MGP remains uncarboxylated and inactive, unable to bind and clear calcium from vessel walls. This is sometimes called the "calcium paradox": adequate calcium intake combined with K2 insufficiency may paradoxically worsen cardiovascular calcification rather than improve bone density. Dr. Cees Vermeer, a leading researcher at Maastricht University who has studied K2 for over three decades, has described uncarboxylated MGP as a reliable biomarker of K2 insufficiency and cardiovascular risk.
Vitamin K2 and Bone Density: What the Evidence Shows
The role of Vitamin K2 in bone metabolism operates through a separate protein: osteocalcin. Like MGP, osteocalcin is a vitamin K-dependent protein; it requires carboxylation (a reaction that depends on K2) to become biologically active. Carboxylated osteocalcin binds calcium ions within bone matrix, facilitating the mineralization process that gives bone its structural integrity. Without sufficient K2, osteocalcin remains undercarboxylated, and bone mineralization is compromised even when calcium and Vitamin D intake are adequate.
Several Japanese clinical trials have examined MK-4 at pharmacological doses (45 mg/day) for the treatment of osteoporosis, with results suggesting reduced fracture rates in postmenopausal women. While these doses exceed what is achievable through diet alone, they validate the biological mechanism. Importantly, the synergy between Vitamin K2 and Vitamin D3 is significant: Vitamin D3 upregulates the production of osteocalcin and MGP, increasing the demand for K2 to activate these proteins. Taking D3 without adequate K2 may leave these proteins stranded in inactive form. Chris Kresser, a functional medicine practitioner and researcher who has written extensively on ancestral nutrition, has consistently emphasized that K2 and D3 should be considered as a nutrient pair rather than independent supplements. This co-dependency is one of the strongest arguments for obtaining these nutrients from whole-food sources where they naturally co-occur, as they do in grass-fed organ meats.
Weston A. Price and the Discovery of Activator X
Long before the biochemistry of menaquinones was understood, a dentist and researcher named Weston A. Price identified a fat-soluble factor in the diets of traditional populations that correlated with exceptional skeletal development, dental health, and resistance to chronic disease. Price traveled to isolated communities across the world in the 1930s, documenting the foods that distinguished the diets of those with robust health from populations that had adopted modern industrialized diets. He called this mysterious compound "Activator X," noting its high concentration in the organ meats, butterfat, and fish eggs of traditional cultures, and its virtual absence in the industrialized food supply.
Decades later, nutritional researcher Sally Fallon Morell and researcher Chris Masterjohn made a compelling case that Activator X was, in all likelihood, Vitamin K2 in its MK-4 form. Masterjohn published an analysis in the Wise Traditions journal arguing that the distribution of Activator X across food sources (high in grass-fed butter, liver, kidney, and certain fish) aligned precisely with the known distribution of MK-4 in animal tissues. While this identification remains somewhat inferential, the convergence between Price's empirical observations and contemporary K2 biochemistry is striking, and it offers historical depth to an otherwise purely molecular story. Price was, in effect, documenting K2 deficiency at a population level before the nutrient had been characterized.
Why Grass-Fed Animals Produce Dramatically More Vitamin K2
The K2 content of animal products is not fixed. It varies enormously based on what the animal ate. Ruminants such as cattle convert Vitamin K1 from green plant material into MK-4 in their tissues, with the liver, kidney, and fat being the primary sites of accumulation. This conversion is meaningful only when the animal is consuming adequate amounts of K1-rich green grass. A grain-fed animal raised in a feedlot has minimal access to fresh green pasture and consequently produces far less K2 in its tissues and fat.
Research on the nutritional composition of grass-fed versus grain-fed beef, including work cited by the American Grassfed Association and nutritional analyses published in academic food science literature, consistently shows that grass-fed beef products contain significantly higher concentrations of fat-soluble vitamins including K2. Butterfat from 100% pasture-raised cows contains substantially more MK-4 than conventional butter, a difference that has been observed across multiple countries and production systems. This is not a marketing claim; it reflects a straightforward biological pathway. The more green grass, the more K1 ingested, the more MK-4 synthesized and deposited in liver and fat tissue. This is precisely why Rise Nutrition sources exclusively from grass-fed cattle pasture-raised in New Zealand and Australia: the nutrient density of the final product depends entirely on the quality of the animal's diet, and there is no shortcut.
Food Sources of K2: A Practical Comparison
Understanding where K2 occurs in food helps explain why deficiency is common even in populations with high overall protein intake. The richest dietary sources of MK-4 include grass-fed liver, grass-fed butter and ghee, egg yolks from pasture-raised hens, and certain organ meats including kidney and brain. Natto, the fermented soybean product widely consumed in Japan, is exceptionally rich in MK-7 but is rarely eaten in Western diets. Hard cheeses from European traditions (gouda, brie, edam) contain modest amounts of MK-7 from the bacterial fermentation involved in aging, but far less than natto.
By contrast, muscle meat, even from grass-fed animals, contains relatively little K2. This is one of the clearest nutritional arguments for including organ meats in a regular diet: they are not simply "more of" what muscle meat provides. They are qualitatively different tissues with distinct nutrient profiles. A serving of grass-fed beef liver delivers K2 concentrations that cannot be replicated by any amount of muscle meat, regardless of sourcing quality. For individuals who do not regularly consume liver, kidney, or fermented foods rich in MK-7, a concentrated grass-fed organ supplement represents a practical and historically grounded solution. Rise Nutrition's beef organ complex brings together liver, heart, kidney, pancreas, and spleen from grass-fed cattle pasture-raised in New Zealand and Australia: the same combination of organs that ancestral populations relied on, and that Price documented in the traditional diets associated with the best health outcomes he observed.
Vitamin K2 Deficiency: Who Is at Risk and What It Means
Vitamin K2 does not have an established Recommended Dietary Allowance (RDA) in Canada. Health Canada's Dietary Reference Intakes for Vitamin K are set for K1, which handles coagulation, and are met by typical vegetable intake. K2 has no separate population-level intake target, which means deficiency is not tracked systematically through national nutrition surveys. This creates a situation in which a nutritionally significant gap in population diets goes largely unmeasured. The Canadian Community Health Survey (Nutrition), administered by Statistics Canada, does not isolate K2 as a distinct analyte in dietary analysis.
Populations at elevated risk for K2 insufficiency include those avoiding animal fats on low-fat dietary protocols, individuals on long-term broad-spectrum antibiotic regimens that deplete gut bacteria capable of producing some K2, and people consuming predominantly muscle meat rather than organs or fermented foods. Individuals taking Vitamin D3 supplements without a corresponding dietary source of K2 may also be functionally insufficient given the increased demand D3 creates for K2-dependent proteins. The solution in most cases is dietary rather than pharmacological: regular consumption of grass-fed organ meats, pastured egg yolks, and quality fermented dairy provides a meaningful and well-absorbed supply of MK-4 in a form the body has been working with for millennia. Rise Nutrition was built around that premise.
If you are looking to close the K2 gap with a whole-food-sourced supplement derived from grass-fed, grass-finished cattle, start here.
Related reading: See grass-fed vs grass-finished: why the difference matters and the full nutrient breakdown of beef organs.
